ES8501635A1 - Un procedimiento de fraccionamiento de plasma sanguineo - Google Patents

Un procedimiento de fraccionamiento de plasma sanguineo

Info

Publication number
ES8501635A1
ES8501635A1 ES531132A ES531132A ES8501635A1 ES 8501635 A1 ES8501635 A1 ES 8501635A1 ES 531132 A ES531132 A ES 531132A ES 531132 A ES531132 A ES 531132A ES 8501635 A1 ES8501635 A1 ES 8501635A1
Authority
ES
Spain
Prior art keywords
fractionation
plasma
blood plasma
exchanger
support particulates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES531132A
Other languages
English (en)
Other versions
ES531132A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rhone Poulenc Recherches SA
Institut Merieux SA
Original Assignee
Rhone Poulenc Recherches SA
Institut Merieux SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Recherches SA, Institut Merieux SA filed Critical Rhone Poulenc Recherches SA
Publication of ES8501635A1 publication Critical patent/ES8501635A1/es
Publication of ES531132A0 publication Critical patent/ES531132A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J39/00—Cation exchange; Use of material as cation exchangers; Treatment of material for improving the cation exchange properties
    • B01J39/08—Use of material as cation exchangers; Treatment of material for improving the cation exchange properties
    • B01J39/16—Organic material
    • B01J39/17—Organic material containing also inorganic materials, e.g. inert material coated with an ion-exchange resin
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J47/00—Ion-exchange processes in general; Apparatus therefor
    • B01J47/014—Ion-exchange processes in general; Apparatus therefor in which the adsorbent properties of the ion-exchanger are involved, e.g. recovery of proteins or other high-molecular compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Inorganic Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)

Abstract

METODO DE FRACCIONAMIENTO DE PLASMA SANGUINEO MEDIANTE CAMBIADORES DE IONES.CONSISTE EN PASAR UNA DISOLUCION DE PLASMA A TRAVES DE, AL MENOS, UN SOPORTE PARCIALMENTE HIDROFOBO, CAMBIADOR DE ANIONES, Y, AL MENOS, UN SOPORTE HIDROFILO CAMBIADOR DE CATIONES.TIENE APLICACION PARA LA OBTENCION DE ALBUMINA DE ELEVADA PUREZA.
ES531132A 1983-04-01 1984-03-30 Un procedimiento de fraccionamiento de plasma sanguineo Granted ES531132A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8305441A FR2543448A1 (fr) 1983-04-01 1983-04-01 Procede de fractionnement du plasma

Publications (2)

Publication Number Publication Date
ES8501635A1 true ES8501635A1 (es) 1984-12-01
ES531132A0 ES531132A0 (es) 1984-12-01

Family

ID=9287485

Family Applications (1)

Application Number Title Priority Date Filing Date
ES531132A Granted ES531132A0 (es) 1983-04-01 1984-03-30 Un procedimiento de fraccionamiento de plasma sanguineo

Country Status (16)

Country Link
US (1) US4675384A (es)
EP (1) EP0121468B1 (es)
JP (1) JPS6023320A (es)
AR (1) AR242115A1 (es)
AT (1) ATE32304T1 (es)
AU (1) AU565104B2 (es)
CA (1) CA1203478A (es)
DE (1) DE3469132D1 (es)
DK (1) DK164741C (es)
ES (1) ES531132A0 (es)
FR (1) FR2543448A1 (es)
IE (1) IE57598B1 (es)
IN (1) IN160634B (es)
MX (1) MX7676E (es)
NO (1) NO166230C (es)
ZA (1) ZA842204B (es)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT399095B (de) * 1986-03-27 1995-03-27 Vukovich Thomas Dr Verfahren zur auftrennung von proteinen mittels gradientenelution und vorrichtung zur durchführung des verfahrens
US4920152A (en) * 1986-05-13 1990-04-24 Purdue Research Foundation Reversed-phase packing material and method
US4911910A (en) * 1986-11-25 1990-03-27 Biotech Research Labs, Inc. Purified equine immunologlobulins and method of use thereof
US4806346A (en) * 1986-12-16 1989-02-21 American Home Products Corporation Method for isolation of antigen specific immunoglobulin
US4897197A (en) * 1987-06-17 1990-01-30 Dow Corning Corporation Using liquid chromatography packing materials
US4773994A (en) * 1987-06-17 1988-09-27 Dow Corning Corporation Liquid chromatography packing materials
US4941974A (en) * 1987-06-17 1990-07-17 Dow Corning Corporation Method of making liquid chromatography dual zone packing materials
US4855054A (en) * 1987-06-17 1989-08-08 Dow Corning Corporation Using liquid chromatography dual zone packing materials
US4778600A (en) * 1987-06-17 1988-10-18 Dow Corning Corporation Liquid chromatography dual zone packing materials
US4959340A (en) * 1987-06-17 1990-09-25 Dow Corning Corporation Method of making liquid chromatography packing materials
US4950634A (en) * 1988-02-11 1990-08-21 Dow Corning Corporation Method for producing dual zone materials by use of an organosilane mixture
US4950635A (en) * 1988-02-11 1990-08-21 Dow Corning Corporation Method for producing dual zone materials by catalyzed halosilylation
JP3554796B2 (ja) * 1988-10-31 2004-08-18 三菱ウェルファーマ株式会社 アルブミン製剤及びその製造方法
US5277818A (en) * 1988-10-31 1994-01-11 The Green Cross Corporation Albumin preparation and process for preparing the same
GB8913183D0 (en) * 1989-06-08 1989-07-26 Central Blood Lab Authority Chemical products
FR2648048B1 (fr) * 1989-06-08 1994-06-03 Lille Transfusion Sanguine Procede de preparation de solutions d'albumine purifiee
US5215908A (en) * 1989-06-13 1993-06-01 Genencor International, Inc. Process for recovery and purification of chymosin
JPH0768137B2 (ja) * 1989-06-15 1995-07-26 株式会社ミドリ十字 アルブミン製剤及びその製法
US5250662A (en) * 1989-10-05 1993-10-05 Alpha Therapeutic Corporation Albumin purification
ATE269872T1 (de) * 1990-04-19 2004-07-15 Bayer Ag Methode zur herstellung von im wesentlichen monomeren normalen menschlichen serum-albumin
AT402261B (de) * 1991-01-25 1997-03-25 Immuno Ag Komplex enthaltend den gerinnungsfaktor ix
FR2672604B1 (fr) * 1991-02-07 1995-05-05 Pasteur Merieux Serums Vacc Procede pour isoler de l'albumine humaine a partir du surnageant iv, notamment iv-4, ou de la fraction v de cohn ou d'un surnageant ou fraction analogue.
US5186838A (en) * 1991-03-04 1993-02-16 Biotage Inc. Chromatographic packing material having functionalized polymeric coating on a substrate
US5167822A (en) * 1991-03-04 1992-12-01 Biotage Inc. Butadiene acrylonitrile polymeric coating for chromatographic packing material
WO1992015385A1 (en) * 1991-03-04 1992-09-17 Simon Ethan S Butadiene acrylonitrile polymeric coating and chromatographic packing material
JPH06501033A (ja) * 1991-07-12 1994-01-27 ギスト　ブロカデス　ナムローゼ　フェンノートシャップ 血清アルブミンの精製方法
US5521287A (en) * 1992-05-20 1996-05-28 The Green Cross Corporation Recombinant human serum albumin, process for producing the same and pharmaceutical preparation containing the same
ES2046122B1 (es) * 1992-06-04 1994-10-01 Grifols Grupo Sa Procedimiento para la obtencion de albumina serica humana purificada.
US5728553A (en) * 1992-09-23 1998-03-17 Delta Biotechnology Limited High purity albumin and method of producing
US5512169A (en) * 1992-12-30 1996-04-30 Dow Corning Corporation Liquid column packing materials
FR2706466B1 (fr) * 1993-06-14 1995-08-25 Aetsrn Concentré d'immunoglobulines G à usage thérapeutique et procédé de production dudit concentré.
US5486293A (en) * 1994-03-21 1996-01-23 Hemasure, Inc. Removal of small exogenous molecules from biological fluids
JP3702474B2 (ja) 1994-06-01 2005-10-05 三菱ウェルファーマ株式会社 血清アルブミン製剤の製造方法
US6114466A (en) * 1998-02-06 2000-09-05 Renal Tech International Llc Material for purification of physiological liquids of organism
GB9902000D0 (en) 1999-01-30 1999-03-17 Delta Biotechnology Ltd Process
AUPP971399A0 (en) * 1999-04-12 1999-05-06 Life Therapeutics Limited Separation of plasma components
US6833238B2 (en) * 2002-01-04 2004-12-21 Applera Corporation Petal-array support for use with microplates
US20040018559A1 (en) * 2002-07-26 2004-01-29 Applera Corporation Size-exclusion ion-exchange particles
US6861473B2 (en) * 2003-02-28 2005-03-01 Baxter International Inc. Macromolecular ketoaldehydes
US20050196856A1 (en) * 2004-02-18 2005-09-08 Applera Corporation Polyelectrolyte-coated size-exclusion ion-exchange particles
US20060160122A1 (en) * 2004-02-18 2006-07-20 Applera Corporation Polyelectrolyte-coated size-exclusion ion-exchange particles
US20050181378A1 (en) * 2004-02-18 2005-08-18 Applera Corporation Polyelectrolyte-coated size-exclusion ion-exchange particles
US8293242B2 (en) * 2005-09-01 2012-10-23 Plasma Technologies, Llc Ultra-high yield of alpha-1-anti-trypsin
US20070049732A1 (en) * 2005-09-01 2007-03-01 Zurlo Eugene J Ultra-high yield intravenous immune globulin preparation
US7879332B2 (en) * 2005-09-01 2011-02-01 Plasma Technologies, Llc Ultra-high yield intravenous immune globulin preparation
US20090118381A1 (en) * 2006-12-04 2009-05-07 Berkeley Heartlab, Inc. Separation of High Density Lipoproteins on Polymer Monoliths with Decreased Hydrophobicity
DE102007038413A1 (de) * 2007-08-09 2009-02-12 Beiersdorf Ag Kosmetische Emulgatorkombination
FR2952639B1 (fr) * 2009-11-16 2013-08-30 Lab Francais Du Fractionnement Procede de purification de facteur b
US20140031527A1 (en) * 2012-07-27 2014-01-30 Csl Limited Method for polishing albumin
JP6397422B2 (ja) * 2012-11-13 2018-09-26 ジーイー・ヘルスケア・バイオプロセス・アールアンドディ・アクチボラグ マルチモーダルアニオン交換マトリックス
PL2735360T3 (pl) * 2012-11-26 2017-09-29 Gambro Lundia Ab Urządzenie adsorbujące łączące granulki i membrany z włókien kanalikowych
US9663553B2 (en) 2014-01-29 2017-05-30 Hemarus Therapeutics Limited Integrated process for the production of therapeutics (human albumin, immunoglobulins, clotting factor VIII and clotting factor IX) from human plasma
EP2985076B1 (en) * 2014-08-15 2022-03-30 Merck Patent GmbH Purification of immunoglobulins from plasma
FR3040882A1 (fr) * 2015-09-10 2017-03-17 Lab Francais Du Fractionnement Composition liquide d'albumine humaine a usage therapeutique

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3941718A (en) * 1972-10-03 1976-03-02 Gaf Corporation Insoluble crosslinked homopolymers and copolymers, polymerized on an inert substrate
CA1009217A (en) * 1972-10-03 1977-04-26 Frederick Grosser Insoluble crosslinked homopolymers and copolymers, polymerized on an inert substrate
US4025500A (en) * 1974-06-06 1977-05-24 Baxter Laboratories, Inc. Preparation of albumin by fractionation of blood plasma or serum
LU73094A1 (es) * 1975-07-29 1977-03-24
FR2359634A2 (fr) * 1976-07-28 1978-02-24 Rhone Poulenc Ind Procede de separation de proteines par echange d'ions
FR2321932A1 (fr) * 1975-08-28 1977-03-25 Rhone Poulenc Ind Procede de separation de proteines par echange d'ions
SE405549B (sv) * 1975-10-09 1978-12-18 Pharmacia Fine Chemicals Ab Forfarande for isolering av albumin ur plasmaprodukter genom kromatografisk fraktionering
US4229342A (en) * 1977-05-18 1980-10-21 Rhone-Poulenc Industries Process for extracting proteins from milk using silica and anion exchange resins
US4136094A (en) * 1977-08-31 1979-01-23 The Regents Of The University Of Minnesota Preparation of intravenous human and animal gamma globulins and isolation of albumin
FR2403098A1 (fr) * 1977-09-19 1979-04-13 Merieux Inst Nouveau materiau capable de fixer de facon reversible des macromolecules biologiques, sa preparation et son application
US4176056A (en) * 1978-04-27 1979-11-27 Pennwalt Corporation Cyclic operation of a bed of mixed ion exchange resins
US4228154A (en) * 1979-02-26 1980-10-14 Armour Pharmaceutical Company Purification of plasma albumin by ion exchange chromatography
JPH115684A (ja) * 1997-06-13 1999-01-12 Nissei Eng:Kk チャック吊り上げ装置

Also Published As

Publication number Publication date
JPS6023320A (ja) 1985-02-05
MX7676E (es) 1990-08-02
US4675384A (en) 1987-06-23
FR2543448A1 (fr) 1984-10-05
IE840802L (en) 1984-10-01
IN160634B (es) 1987-07-18
AR242115A1 (es) 1993-03-31
EP0121468A3 (en) 1985-07-17
DK174484D0 (da) 1984-03-30
DK174484A (da) 1984-10-02
DK164741C (da) 1992-12-28
CA1203478A (fr) 1986-04-22
NO841266L (no) 1984-10-02
AU565104B2 (en) 1987-09-03
AU2626484A (en) 1984-10-04
ZA842204B (en) 1984-10-31
EP0121468A2 (fr) 1984-10-10
NO166230C (no) 1991-06-19
JPH0520439B2 (es) 1993-03-19
ATE32304T1 (de) 1988-02-15
DE3469132D1 (en) 1988-03-10
DK164741B (da) 1992-08-10
ES531132A0 (es) 1984-12-01
EP0121468B1 (fr) 1988-02-03
NO166230B (no) 1991-03-11
IE57598B1 (en) 1993-01-27

Similar Documents

Publication Publication Date Title
ES8501635A1 (es) Un procedimiento de fraccionamiento de plasma sanguineo
EP0119954A3 (en) 3-amino-1-benzazepin-2-one-1-alcanoic acids, process for their preparation, their pharmaceutical preparation as well as their therapeutic use
UA39135C2 (uk) Спосіб фракціонування розчину
FR2603581B1 (fr) Procede pour isoler et purifier des aminoacides par chromatographie
RO85046A (ro) Procedeu de preparare a berii nealcolice
BE901792A (fr) Solution ophtalmique et son procede de preparation.
AU591879B2 (en) A method for purifying a physiologically active substance produced by recombinant DNA technique
TNSN88111A1 (fr) Procede de purification d'une proteine
GB1300068A (en) Apparatus for purifying blood
FR2487642B2 (fr) Procede de preparation de fractions proteiques par ultrafiltration et chromatographie d'exclusion et d'echange d'ions
ES8407499A1 (es) Un metodo para la obtencion de interferon inmune humano homogeneo de pureza aumentada.
JPS646292A (en) Manufacture of active-form protein
IE893155L (en) A method for separating glycolipids from a lipid mixture and¹uses of the fractions obtained
ZA821637B (en) Oxazaphosphorin-4-thio-alkanesulfonic acids, neutral salts thereof, processes for the production thereof and pharmaceutical preparations containing them
FR2381783A1 (fr) Procede de production de lysozyme humaine
FR2584734B1 (fr) Procede d'hydrogenation d'olefines en presence d'ethers
IT8449183A0 (it) Soluzione proteinica per somministrazione parenterale in malattie croniche da carenza di proteine
GB2126920B (en) Liquid active substance-containing membrane and process for its production
MA20150A1 (fr) Derives de l'acide bicyclo (3,2-1) octane carboxylique et leur procede de preparation et leur application therapeutique.
FR2616782B1 (fr) Procede de separation d'acides amines
FR2586612B1 (fr) Procede pour la preparation d'elements pre-moules pour la production de lentilles de contact par usinage
GR3003950T3 (es)
ES285700U (es) Monopatin
FR2567393B1 (fr) Procede photodigital, permettant l'amelioration de l'etude de l'empreinte plantaire
PL255010A1 (en) Column for preparative liquid chromatography,in particular for use in production processes